Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T02:40:41.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T23:16:18.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.1%
    Check dated 2024-12-15T00:25:02.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The study status has changed from 'Recruiting' to 'Active, not recruiting', and the contact details for study inquiries have been updated to provide new information on where the study is taking place.
    Difference
    7%
    Check dated 2024-12-07T21:55:43.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Several key resources related to lymphoma and rare diseases have been removed, including links to MedlinePlus and NIH, which may impact access to important health information.
    Difference
    4%
    Check dated 2024-11-23T06:23:26.000Z thumbnail image
  9. Check
    71 days ago
    Change Detected
    Summary
    New resources related to lymphoma and Hodgkin lymphoma have been added, including links to MedlinePlus, NIH, and DailyMed, which may provide valuable information for users interested in these conditions.
    Difference
    0.5%
    Check dated 2024-11-16T02:03:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.